PetMed Express (NASDAQ:PETS) Rating Increased to Hold at Wall Street Zen

PetMed Express (NASDAQ:PETS) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Friday.

PetMed Express Stock Up 0.3%

PETS opened at $3.05 on Friday. PetMed Express has a 52-week low of $2.81 and a 52-week high of $6.85. The company has a 50 day moving average of $3.23 and a two-hundred day moving average of $3.57. The company has a market cap of $63.00 million, a P/E ratio of 305.31 and a beta of 0.77.

Insider Transactions at PetMed Express

In other PetMed Express news, major shareholder Silvercape Investments Ltd acquired 101,000 shares of the firm’s stock in a transaction on Wednesday, August 13th. The stock was bought at an average cost of $3.17 per share, for a total transaction of $320,170.00. Following the completion of the purchase, the insider directly owned 2,579,696 shares in the company, valued at $8,177,636.32. This represents a 4.07% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have purchased 271,283 shares of company stock worth $865,256 in the last ninety days. 1.10% of the stock is owned by insiders.

Institutional Investors Weigh In On PetMed Express

Several institutional investors have recently bought and sold shares of the business. Truffle Hound Capital LLC purchased a new position in shares of PetMed Express in the second quarter valued at $399,000. Formidable Asset Management LLC boosted its stake in shares of PetMed Express by 394.5% in the fourth quarter. Formidable Asset Management LLC now owns 135,251 shares of the company’s stock valued at $652,000 after purchasing an additional 107,902 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of PetMed Express in the first quarter valued at $295,000. Caption Management LLC purchased a new position in shares of PetMed Express in the first quarter valued at $242,000. Finally, PharVision Advisers LLC purchased a new position in shares of PetMed Express in the fourth quarter valued at $178,000. 73.33% of the stock is currently owned by hedge funds and other institutional investors.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.